Wanderer’s Weekly Travel News (Week of June 21, 2021)


We’re sharing travel news and updates from across the globe every Wednesday so that you can stay up to date with all things travel.

Sign-up to have Wanderer’s Weekly Travel News delivered to your inbox each week.

Scroll through to get overviews of the latest travel news, European travel updates, travel trends, COVID-19 updates, and more.


Wanderer’s Weekly Travel News for the week of June 21, 2021

European Travel News


“U.S. Tourists Can Now Travel to Italy without Quarantining”

– via Condé Nast Traveler

As of Monday, June, 21st, American travelers are now eligible to enter Italy under the requirements of the EU’s Green Certificate. Where will you go first?

Read the full article


“Travel guide to Spain, Portugal, France and more holiday hotspots”

– via BBC News

All the need-to-know details about visiting Portugal, Spain, Greece, France, Italy, and Turkey.

Read the full article

Travel Trends News


“How Travel Companies Can Inspire Informed Travel During The Pandemic”

– via Forbes

Traveling in 2021 is more complicated than ever before, learn how travel companies can help you stay informed to travel safely and stress free.

Read the full article


“Europe travel is complicated. Take these 7 tips from travelers who just went.”

– The Washington Post

Learn the need to know tips for visiting Europe this summer from traveler’s who have gone through it!

Read the full article

COVID-19 Travel News


“AstraZeneca, Pfizer vaccines effective against Delta COVID-19 variants-study”

– via Reuters

“COVID-19 vaccines made by AstraZeneca (AZN.L) and the Pfizer-BioNTech (PFE.N), (22UAy.DE) alliance remain broadly effective against Delta and Kappa variants of the COVID-19 causing virus, which were first identified in India, according to a scientific study, underpinning a continued push to deliver the shots.”

Read the full article


“A long-term perspective on immunity to COVID”

– via Nature

“Determining the duration of protective immunity to infection by SARS-CoV-2 is crucial for understanding and predicting the course of the COVID-19 pandemic. Clinical studies now indicate that immunity will be long-lasting.”

Read the full article